Further, upregulation of selectins and CD93, CD248, and CLEC14a on tumor ECs prompt investigation as to whether group XIV CTLDs can serve as a mediator or master regulator of the activated EC phenotype in the face of tumor-derived signals as is described for E-selectin. Here, SELE is linked to neoplasm.